Adult men with erectile dysfunction may use Abhigra tablets to support erections during sexual stimulation. The product contains sildenafil, a PDE5 inhibitor that improves penile blood flow and helps an erection develop and persist when sexual arousal is present.
Abhigra is a sildenafil-based medicine for erectile dysfunction in adult men. Its active ingredient belongs to the PDE5 inhibitor category and supports the vascular response involved in erections.
Sexual stimulation activates nerve pathways that release nitric oxide in penile tissue. Nitric oxide increases cGMP, which relaxes smooth muscle and allows the blood vessels supplying the penis to widen. PDE5 normally reduces cGMP activity; sildenafil slows this breakdown.
The result is improved blood inflow during sexual arousal. Sildenafil does not permanently increase blood flow, alter testosterone production, or cure the underlying cause of erectile dysfunction.
PDE5 inhibition also explains several unwanted effects. The same blood-vessel relaxation that supports penile blood flow can contribute to headache, facial flushing, nasal congestion, indigestion, dizziness, or a temporary change in colour perception. These effects are more likely when the medicine produces stronger systemic vasodilation.
The FDA-approved prescribing information describes its use in adult men, while the European Medicines Agency evaluates sildenafil within the PDE5 inhibitor class [1].
Abhigra contains sildenafil citrate, a selective phosphodiesterase type 5 inhibitor used for erectile dysfunction. Sildenafil does not create sexual desire and does not produce an erection without sexual stimulation. Its role is to strengthen the natural vascular response that follows arousal.
Sildenafil citrate is converted into sildenafil in the body. The active substance then inhibits PDE5, an enzyme that breaks down cyclic guanosine monophosphate, commonly called cGMP. Higher cGMP activity allows smooth muscle in the penile blood vessels to relax, improving local blood flow.
The usual clinical purpose of Abhigra is the treatment of erectile dysfunction in adult men. The condition may involve difficulty obtaining an erection, difficulty maintaining it, or erections that are not firm enough for satisfactory sexual activity.
The regimen for the chosen Abhigra strength should be confirmed with a healthcare professional before starting treatment.
The regimen for the chosen Abhigra strength must be confirmed with a healthcare professional before starting. Abhigra is taken orally as a tablet before anticipated sexual activity.
The timing of response varies between men. Many patients notice an effect within about 30–60 minutes, while a large meal, alcohol, anxiety, or inadequate stimulation may make the response slower or less reliable. The effect is temporary and does not continue indefinitely.
The tablet should not be crushed or altered unless a prescriber specifically instructs this. Changing the dosage form can interfere with the intended administration and makes accidental dosing errors more likely.
If the erection lasts longer than four hours, emergency medical care is required. A prolonged erection can damage penile tissue even when it is not painful at first.
Do not use sildenafil with nitrate medicines such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate. Nitrates may be prescribed for angina or other heart conditions. The combination can cause a dangerous fall in blood pressure and is identified as a major contraindication in regulatory prescribing information [3].
Sildenafil must also be avoided with riociguat, a soluble guanylate cyclase stimulator used for certain forms of pulmonary hypertension. Both medicines affect the nitric oxide–cGMP pathway, so their combined effect may cause severe hypotension.
Extra caution is needed with:
Alpha-blockers, some antihypertensive medicines, and strong CYP3A4 inhibitors can increase the blood-pressure or sildenafil exposure effects. Examples of CYP3A4 inhibitors include ritonavir, ketoconazole, itraconazole, and some macrolide antibiotics. A prescriber may need to adjust treatment or select another option.
Abhigra is not suitable for every man with erectile dysfunction. Do not use it if you take nitrates or riociguat, have been advised to avoid sexual activity, or have an unstable cardiovascular condition. Tell a prescriber about heart disease, recent stroke or heart attack, blood-pressure problems, liver or kidney disease, eye disorders, penile abnormalities, or previous prolonged erections before treatment.
The most commonly reported reactions with sildenafil are headache, flushing, indigestion, nasal congestion, dizziness, and visual changes. These effects are linked to vascular relaxation or PDE5 activity in tissues outside the penis. They are often mild and temporary, but a stronger reaction can require medical assessment.
Temporary visual symptoms may include a blue or altered colour tint, increased sensitivity to light, or blurred vision. The FDA prescribing information identifies visual disturbances as a recognised adverse effect and warns about rare serious eye events [2].
Dizziness is more likely when sildenafil lowers blood pressure in combination with alcohol, dehydration, blood-pressure medicines, or other vasodilators. Sitting down and avoiding driving until the sensation has passed can reduce immediate injury risk.
Stop using Abhigra and seek urgent medical care for chest pain, fainting, severe shortness of breath, sudden loss of vision, sudden loss of hearing, or an erection lasting more than four hours. A severe allergic reaction with facial swelling, wheezing, or difficulty breathing also requires emergency treatment.
The usual clinical purpose of Abhigra is the treatment of erectile dysfunction in adult men. The condition may involve difficulty obtaining an erection, difficulty maintaining it, or erections that are not firm enough for satisfactory sexual activity.
| Approach | Main action | Practical limitation |
|---|---|---|
| Abhigra tablets | PDE5 inhibition and improved blood flow during arousal | Requires sexual stimulation and is unsuitable with nitrates |
| Lifestyle treatment | Improves vascular, metabolic, and psychological contributors | Benefits usually develop gradually |
| Psychological or relationship therapy | Addresses anxiety, stress, or relationship factors | Less useful when vascular disease is the main cause |
Abhigra may be useful when erectile dysfunction is linked to reduced vascular responsiveness and the man can safely use a PDE5 inhibitor. Lifestyle treatment remains valuable for smoking, obesity, uncontrolled diabetes, high blood pressure, and inactivity because these factors can worsen erectile function.
Counselling or sex therapy may help when erections are present in some situations but not others, or when fear of failure causes a cycle of anxiety. Some men need both approaches. A PDE5 inhibitor can improve the physical response while therapy addresses the emotional trigger.
Sildenafil is generally used on demand. Daily medicines, vacuum devices, injections, or surgery involve different mechanisms and clinical decisions, so they should not be substituted without medical assessment.
In clinical practice, doctors usually assess erectile dysfunction as a possible vascular symptom rather than treating the erection alone. Erectile problems can occur before other signs of cardiovascular disease because penile arteries are smaller and may show impaired circulation earlier.
A doctor will usually ask about chest pain, exercise tolerance, diabetes, blood pressure, smoking, alcohol intake, mood, sleep, and current medicines. This information helps determine whether a PDE5 inhibitor is appropriate and whether cardiovascular assessment is needed.
Sildenafil is often considered when the patient can engage in sexual activity safely and has no nitrate treatment. Expectations should remain realistic: the tablet supports the physiological response, but it does not replace sexual stimulation, resolve relationship problems, or reverse severe untreated vascular disease.
A 2025 review in the Journal of Sexual Medicine continued to support the role of PDE5 inhibitors in erectile dysfunction while emphasising individual assessment and cardiovascular safety. The WHO also recognises erectile dysfunction as a health condition that can have physical and psychological contributors [4].
Sildenafil can cause dizziness, headache, blurred vision, or temporary colour-vision changes, which may impair driving or machinery work. The FDA prescribing information advises caution until the individual response is known . During 2026, the same practical rule remains relevant: do not drive or operate machinery if you feel dizzy or your vision changes.
Stop using Abhigra and seek urgent help for chest pain, fainting, severe breathing difficulty, sudden hearing loss, sudden vision loss, or an erection lasting more than four hours. These symptoms can indicate a serious cardiovascular, ocular, auditory, allergic, or urological complication. EMA safety information from 2024 identifies prolonged erection and sudden sensory loss as symptoms requiring immediate assessment.
Older adults may use sildenafil when a prescriber confirms that sexual activity and the medicine are suitable. Age can increase the likelihood of cardiovascular disease, kidney impairment, liver impairment, and interacting medicines, so the treatment plan may need closer review. Guidance from the European Medicines Agency available in 2026 continues to support individual assessment rather than an age-only decision .
Abhigra is intended for adult men and should not be used by people under 18 for erectile dysfunction. Erectile difficulties in adolescents require assessment of physical health, mental health, medicines, and safeguarding concerns rather than self-treatment. The FDA sildenafil prescribing information from 2023 limits erectile-dysfunction use to adults.
Alcohol can increase dizziness and blood-pressure reduction, while larger amounts may make an erection more difficult to obtain or maintain. Avoid heavy drinking around the time of sexual activity, especially if you also use antihypertensive treatment. NHS advice available in 2025 similarly emphasised moderation because alcohol can worsen erectile dysfunction itself.
Abhigra is intended for men and has no routine role in pregnancy or breastfeeding. Women who are pregnant or breastfeeding should not use sildenafil for erectile dysfunction unless a specialist has prescribed it for a different medical indication. The WHO’s reproductive-health information available in 2025 supports avoiding unnecessary medicine exposure during pregnancy and lactation.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
